Compare ABT & SHEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABT | SHEL |
|---|---|---|
| Founded | 1888 | 1907 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.8B | 208.6B |
| IPO Year | N/A | N/A |
| Metric | ABT | SHEL |
|---|---|---|
| Price | $122.48 | $72.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 9 |
| Target Price | ★ $146.61 | $80.76 |
| AVG Volume (30 Days) | ★ 6.6M | 4.0M |
| Earning Date | 01-21-2026 | 01-29-2026 |
| Dividend Yield | 1.93% | ★ 3.93% |
| EPS Growth | ★ 141.97 | N/A |
| EPS | ★ 7.96 | 2.42 |
| Revenue | $43,843,000,000.00 | ★ $269,075,000,000.00 |
| Revenue This Year | $7.56 | N/A |
| Revenue Next Year | $7.96 | N/A |
| P/E Ratio | ★ $15.39 | $30.13 |
| Revenue Growth | ★ 6.37 | N/A |
| 52 Week Low | $110.86 | $58.55 |
| 52 Week High | $141.23 | $77.47 |
| Indicator | ABT | SHEL |
|---|---|---|
| Relative Strength Index (RSI) | 37.46 | 43.26 |
| Support Level | $124.06 | $73.57 |
| Resistance Level | $126.05 | $75.18 |
| Average True Range (ATR) | 2.51 | 0.83 |
| MACD | -0.58 | -0.19 |
| Stochastic Oscillator | 18.25 | 21.79 |
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.5 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At year-end 2024, reserves stood at 9.6 billion barrels of oil equivalent, 48% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with a capacity of 1.6 mmb/d located in the Americas, Asia, and Europe, and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.